Point-of-Care C-Reactive Protein Test for Supporting the Management of Respiratory Tract Infections in Western Australian Community Pharmacy: A Feasibility Study

Not Applicable

Completed

• Conditions: pper Respiratory Tract Infections; Upper Respiratory Tract Infections; Respiratory - Other respiratory disorders / diseases; Infection - Other infectious diseases

• Registration Number: ACTRN12619000965101
• Lead Sponsor: Curtin University

Brief Summary

Results of this study is currently embargoed.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-08
• Study Completion: 2019-10-23
• Last Update Posted: 14 September 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 131

Inclusion Criteria

•At least 18 years of age, AND
•Less than 65 years of age, AND
•Able to provide informed consent to participate
•Presenting to the pharmacy with either an RTI-related product request OR RTI symptom, AND
•Seeking advice regarding the need for antibiotics or need to visit a GP

Exclusion Criteria

•Under 18 years of age
•65 years and above
•Presenting with a medical condition that may cause an underlying rise in CRP levels, such as rheumatoid arthritis or other autoimmune conditions
•Immuno-compromised or on a medication that could affect their immune response

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acceptability of CRP testing to pharmacists as assessed by a combined response to a series of 5-point Likert scale questions<br>[Eight weeks after trial commencement];Acceptability of CRP testing to consumers as assessed by a combined response to a series of 5-point Likert scale questions[Immediately after testing and the overall service provision]

Secondary Outcome Measures

Name	Time	Method
Pharmacists' confidence in reporting tests using study specific questionnaire[Eight weeks after trial commencement];Pharmacists' confidence in delivering the service using validated resources and protocols provided, using study specific questionnaire[Eight weeks after trial commencement];Pharmacists' knowledge about point-of-care CRP testing using study specific questionnaire[Eight weeks after trial commencement];Consumers' experience with the service using study specific questionnaire[Immediately after testing and the overall service provision]